Until the underlying community health factors like poverty and education are addressed, disparities in cancer outcomes will persist, according to Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health. She also discussed how health systems and providers can contribute to efforts to improve community health.
Until the underlying community health factors like poverty and education are addressed, disparities in cancer outcomes will persist, according to Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health. She also discussed how health systems and providers can contribute to efforts to improve community health.
Transcript (slightly modified)
How do community-level health factors contribute to disparities in cancer care?
Community-level health factors, so things like poverty, lack of transportation, educational attainment, all of those things have a great deal of impact on cancer health disparities. Personally, I think that until we address those issues in a very meaningful way, we’re going to continue to see the disparities that we see.
How can healthcare providers and health systems work as partners in improving community health?
I think first, by really understanding that it is all of our jobs to address disparities, not only just in cancer, but in any kind of chronic disease issue. Then, being really open and willing to actually say: This is the lane that I know. This is what I know how to do. I may not be the best person in terms of outreach, but let me figure out who it is that I can partner with to help.
I really think it’s a kind of holistic approach that we need to take in terms of ensuring that providers and health systems not only are talking to each other and paying attention to patient care, but also thinking about and anticipating what those needs are of patients and the communities that they serve. We honestly all have a role to play in that.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More